Edward B. Berg - 16 Mar 2026 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Mar 2026, 19:41:25 UTC
Prior SEC filing
05 Feb 2026
Next SEC filing
20 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Edward B. Berg

Key filing fact

Edward B. Berg filed Form 4 for Vaxart, Inc. (VXRT) on 18 Mar 2026.

Key facts

  • This page summarizes Edward B. Berg's Form 4 filing for Vaxart, Inc. (VXRT).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 18 Mar 2026, 19:41.

Change

  • Previous filing in this sequence was filed on 05 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001912178 Primary reporting owner

Berg Edward B

Relationship
SVP, General Counsel
Address
C/O VAXART, INC., 170 HARBOR WAY, SUITE 300, SOUTH SAN FRANCISCO
Signature
/s/ Edward B. Berg
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VXRT transaction

Common Stock

Award

Transaction value
Shares
+115,000
Change %
+17%
Price
$0.000000*
Shares after
799,858
Date
16 Mar 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VXRT transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares
+225,000
Change %
Price
$0.000000*
Shares after
225,000
Date
16 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
225,000
Exercise price
$0.6795
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Grant of shares upon vesting of restricted stock units. 25% of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 16, 2026, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date.

Footnote F2

The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on March 16, 2027, the first anniversary of the date that vesting commenced, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on March 16, 2030.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .